Corporate Profile

Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity. More >>

Recent NewsMore >>
Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
Rhythm Pharmaceuticals Announces New Topline Clinical Data from Ongoing Phase 2 Basket Studies Evaluating Setmelanotide in Rare Genetic Disorders of Obesity
RYTM (Common Stock) $26.42 Stock is Up 0.25 (0.96%)06/20/18 4:00 p.m. ET
Stock chart for: RYTM.O.  Currently trading at $26.42 with a 52 week high of $34.99 and a 52 week low of $16.80.
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources
Upcoming EventsMore >>
There are currently no events scheduled.